1. Home
  2. VTSI vs RNXT Comparison

VTSI vs RNXT Comparison

Compare VTSI & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.10

Market Cap

51.0M

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.96

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
RNXT
Founded
1993
2012
Country
United States
United States
Employees
N/A
17
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
42.4M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
VTSI
RNXT
Price
$3.10
$0.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$8.25
AVG Volume (30 Days)
38.9K
190.9K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
$185,971.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
$27.30
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$2.88
$0.70
52 Week High
$7.47
$1.45

Technical Indicators

Market Signals
Indicator
VTSI
RNXT
Relative Strength Index (RSI) 48.18 58.73
Support Level $3.05 $0.81
Resistance Level $3.60 $0.98
Average True Range (ATR) 0.14 0.05
MACD 0.02 0.01
Stochastic Oscillator 59.46 93.27

Price Performance

Historical Comparison
VTSI
RNXT

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: